Page last updated: 2024-09-04

ws 79089b and Myocardial Infarction

ws 79089b has been researched along with Myocardial Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emoto, N1
Krum, H; Martin, P; Stein-Oakley, A; Tzanidis, A1

Reviews

1 review(s) available for ws 79089b and Myocardial Infarction

ArticleYear
[Physiological and pathophysiological roles of the endothelin converting enzymes].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Drug Design; Endothelin-Converting Enzymes; Glycopeptides; Heart Failure; Humans; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardial Infarction; Organophosphonates; Phenylalanine; Tetracyclines; Tetrazoles

2004

Other Studies

1 other study(ies) available for ws 79089b and Myocardial Infarction

ArticleYear
Effect of a highly selective endothelin-converting enzyme inhibitor on cardiac remodeling in rats after myocardial infarction.
    Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:5 Suppl 1

    Topics: Animals; Aspartic Acid Endopeptidases; Echocardiography; Endothelin-1; Endothelin-Converting Enzymes; Female; Hemodynamics; Immunohistochemistry; Metalloendopeptidases; Myocardial Infarction; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Tetracyclines; Ventricular Function, Left

2000